Kitang, Kline Yasin S.
HRN: 25-71-58 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2024
CEFUROXIME 750MG (VIAL)
08/19/2024
08/26/2024
IV
450mg
Q8H
ATP - Exudative
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes